Cardinal Health, Inc. (NYSE:CAH) Shares Sold by Crossmark Global Holdings Inc.

Crossmark Global Holdings Inc. decreased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 18.1% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 59,465 shares of the company's stock after selling 13,122 shares during the period. Crossmark Global Holdings Inc.'s holdings in Cardinal Health were worth $8,192,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Principal Financial Group Inc. boosted its stake in shares of Cardinal Health by 5.3% during the first quarter. Principal Financial Group Inc. now owns 315,817 shares of the company's stock worth $43,510,000 after buying an additional 15,956 shares during the period. Huntington National Bank lifted its position in Cardinal Health by 1.2% in the fourth quarter. Huntington National Bank now owns 10,920 shares of the company's stock valued at $1,292,000 after purchasing an additional 128 shares during the period. Kingswood Wealth Advisors LLC lifted its position in Cardinal Health by 17.2% in the first quarter. Kingswood Wealth Advisors LLC now owns 3,119 shares of the company's stock valued at $429,000 after purchasing an additional 457 shares during the period. Golden State Wealth Management LLC lifted its position in Cardinal Health by 569.5% in the first quarter. Golden State Wealth Management LLC now owns 395 shares of the company's stock valued at $54,000 after purchasing an additional 336 shares during the period. Finally, Assenagon Asset Management S.A. lifted its position in Cardinal Health by 25.8% in the first quarter. Assenagon Asset Management S.A. now owns 13,147 shares of the company's stock valued at $1,811,000 after purchasing an additional 2,694 shares during the period. Institutional investors and hedge funds own 87.17% of the company's stock.

Cardinal Health Trading Up 1.6%

Shares of Cardinal Health stock opened at $167.62 on Tuesday. Cardinal Health, Inc. has a 12-month low of $93.17 and a 12-month high of $168.44. The stock has a market cap of $40.01 billion, a PE ratio of 26.15, a price-to-earnings-growth ratio of 1.63 and a beta of 0.68. The company has a 50-day moving average of $156.17 and a two-hundred day moving average of $137.79.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.15 by $0.20. The firm had revenue of $54.88 billion during the quarter, compared to the consensus estimate of $55.33 billion. Cardinal Health had a negative return on equity of 68.84% and a net margin of 0.70%. The company's quarterly revenue was up .0% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.08 EPS. On average, sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be given a dividend of $0.5107 per share. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $2.04 annualized dividend and a yield of 1.22%. Cardinal Health's dividend payout ratio (DPR) is presently 31.83%.

Analysts Set New Price Targets

A number of equities research analysts recently commented on CAH shares. Wells Fargo & Company upgraded shares of Cardinal Health from an "equal weight" rating to an "overweight" rating and raised their price objective for the company from $136.00 to $179.00 in a research report on Tuesday, June 3rd. Evercore ISI restated an "outperform" rating and issued a $180.00 price objective (up previously from $175.00) on shares of Cardinal Health in a research report on Thursday, June 12th. Robert W. Baird raised their price objective on shares of Cardinal Health from $156.00 to $170.00 and gave the company an "outperform" rating in a research report on Friday, May 2nd. Wall Street Zen upgraded shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a research report on Monday, May 5th. Finally, Morgan Stanley set a $181.00 target price on shares of Cardinal Health and gave the company an "overweight" rating in a report on Friday, June 13th. Three equities research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Cardinal Health presently has an average rating of "Moderate Buy" and a consensus price target of $157.43.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.